Advertisement

Das Herz bei Myxödem und Hypothyreose

  • Frank Schaub
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde book series (KINDERHEILK. NF, volume 9)

Zusammenfassung

1880 wurden von Ord erstmals die pathologisch-anatomischen Veränderungen beim sog. Myxödemherzen beschrieben. 1918 hat Zondek, nachdem bereits Falta auf Kreislaufveränderungen beim Myxödem hingewiesen hatte, als erster die für das Myxödem charakteristischen klinischen, röntgenologischen und elektrokardio- graphischen Befunde, die im Wesentlichen bis heute ihre volle Gültigkeit bewahrt haben, als eigentKches Krankheitsbild dargestellt. Seither ist eine kaum übersehbare Zahl von Publikationen über die Klinik des Myxödemherzens erschienen (wir zitieren hier nur die wichtigsten: Andrus, Assmann, Bansi, Bauer, Braid, Calvert, Coelho, Curschmann, Fahr, Gordon, Hallock, Hamburger e. c., Holzman, Lerman, Lesser and Anderson, Means, Meissner, Ohler und Abramson, Richard, Schittenhelm und Eisler, Tung, Werner, Weyker, Zandrén U. a.). Dabei lag im allgemeinen das Hauptgewicht auf der Symptomatologie des voll entwickelten Myxödemherzens bei schweren und schwersten Hypofunktionszuständen der Schilddrüse. In der letzten Dekade hat das Interesse für Schilddrüsenfunktionsstörungen erneut stark zugenommen dank der bedeutenden Fortschritte, die in der funktionellen Diagnostik dieses Organs erzielt wurden, und ebenfalls dank der stark geförderten Kenntnisse des Jod- und Schilddrüsen- Stoffwechsels im allgemeinen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abelin, I., u. M. Goldstein: Über die Rolle des Adrenalins bei der Hyperthyreose. Klin. Wschr. 1956, 1000.Google Scholar
  2. Abrami, P., M. Brulé et J. Heitz: Deux cas d’angine de poitrine avec myxoedème. Aggravation de l’hypertension par l’opothérapie. Buu. Soc. méd. Hop. Paris 49, 712 (1925).Google Scholar
  3. Adlersberg, D., E. T. Bossak, I. H. Sher and H. Sobotblà.: Electrophoresis and Monomolecular Layer Studies with Serum Lipoproteins. Clin. Chemistry 1, 18 (1955).Google Scholar
  4. Aikawa, J. K.: The Nature of Myxedema: Alterations in the Serum Electrolyte Concentrations and Radiosodium Space and in the Exchangeable Sodium-Potassium Contents. Ann. Int. Med. 44, 30 (1956).PubMedGoogle Scholar
  5. Allison, F. G.: Myxedema Heart, Atrial Spetal Defect and Hypertension and Congestive Heart Failure. Amer. Heart J. 41, 620 (1951).PubMedGoogle Scholar
  6. Altschule, M. D., and M. Volk: The minute volume output and the work of the heart in hypothyroidism. J. Clin. Invest. 14, 385 (1935).PubMedGoogle Scholar
  7. Andbus, E. C.: The Thyroid and the Circulation. Circulation (New York) 7, 437 (1953).Google Scholar
  8. Assmann, H.: Das Myxoedemherz. Münch, med. Wschr. 1919, 9.Google Scholar
  9. Aub, J. C., and N. S. Stern: The Influence of Large Doses of Thyroid Extract on the Total Metabolism and Heart in a Case of Heart Block. Arch. Int. Med. 21, 130 (1918).Google Scholar
  10. Aumann, K. W., and W. B. Yotjmans: Differential sensizitation of adrenergic neuroeffector systems by thyroid hormone. Amer. J. Physiol. 131, 394 (1940).Google Scholar
  11. Ayman, D., H. Rosenblitm and M. Palcon-Lesses: “Myxedema Heart” Without Evidence of Cardiac Insufficiency. Report of Two Cases. J. Amer. Med. Assoc. 98, 1721 (1932).Google Scholar
  12. Bansi, H. W.: Zur Pathogenese, Pathophysiologie und Klinik der Hypothyreosen. Münch, med. Wschr. 1955, 97, 1130.Google Scholar
  13. Bansi, H. W.:Krankheiten der Schilddrüse. In Handbuch der Inneren Medizin, Bd. 7, 1. Teil. Springer-Verlag 1955.Google Scholar
  14. Bansi, H. W.: Die Kreislaufgeschwindigkeit beim Morbus Basedow und beim Myxoedem. Z. klin. Med. 116, 583 (1931).Google Scholar
  15. Bansi, H. W.: Die Krankheiten der Schilddrüse. In Handbuch der Inneren Medizin, Bd. 7, I.Teil. Springer-Verlag 1955.Google Scholar
  16. Bansi, H. W. u. F. Fretwtjrst: Zur klinischen Chemie der Hypothyreose. Klin. Wschr. 1954, 887.Google Scholar
  17. Bansi, H. W. u. G. Grosourth: Die Kreislaufleistung beim Basedow und Myxoedem. Z. klin. Med. 116, 583 (1931).Google Scholar
  18. Barker, S. B., J. F. Fazekas and H. E. Himwich: Metabolie Aspects of Thyroid Adrenal interrelationsships. Amer. J. Physiol. 115, 415 (1936).Google Scholar
  19. Barr, D. P.: Some Chemical Factors in the Pathogenesis of Atherosclerosis. Circulation (New York) 8, 641 (1953).Google Scholar
  20. Barr, D. P.: Hormonal Factors in the Pathogenesis of Atherosclerosis. Minnesota Med. 38, 788 (1955).PubMedGoogle Scholar
  21. Barr, D. P., E. M. Rfss and H. A. Eder: Protein-Lipid relationsship in human plasma. II. In aterio- sclerosis and related conditions. Amer. J. Med. 11, 480 (1951).PubMedGoogle Scholar
  22. Bartels, J. H. and A. Bell: Zit. nachE. C. Andrus: The Thyroid and the Circulation. Circulation (NewYork) 7,437 (1953).Google Scholar
  23. Bauer, J.: Das Kropf herz, seine Fehldiagnose und seine Behandlung. Med. Klin. 1953, 1846.Google Scholar
  24. Behr, E., J. Mulber: Het Myxoedemhart een pathologisch-anatomische Bijdrage. Nederl. Z. Geneesk. 1938, 4303.Google Scholar
  25. Ben-Asher, S.: Further Observations on Treatment of the anginal Syndrom with Thiouracil. Amer. Heart. J. 33, 490 (1947).PubMedGoogle Scholar
  26. Benson, W.: Beitrag zur Kenntnis der Organ Veränderungen nach Schüddrüsen-Exstirpation bei Kaninchen. Virchows Arch. 170, 229 (1902).Google Scholar
  27. Bing, R. J.: Der Myokardstoffwechsel. Klin. Wschr. 1956, 1.Google Scholar
  28. Blackford, J. M., and F. A. Willius: Chronic Heart Block. Amer. J. Med. Sei. 154, 585 (1917).Google Scholar
  29. Blalock, A., and T. R. Harrison: Regulation of Circulation Effects of Thyroidectomy and Thyroidectomy and Thyroid Feeding on Cardiac Output. Surg. etc. 44, 1617 (1927).Google Scholar
  30. Blum, F.: Über Nieren-Veränderungen bei Ausfall der Schilddrüsentätigkeit. Virchows Arch. 166, 403 (1901).Google Scholar
  31. Blumgart, H. L.: The Velocity of blood flow in health and disease: The velocity of blood flow in man and its relation to other measurements of the circulation. Medicine 10, 1 (1931).Google Scholar
  32. Blumgart, H. L., and A. S. Freedberg: The Heart and the Thjnroid, with particular reference to J131 Treatment of Heart Disease. Circulation (New York) 6, 222 (1952).Google Scholar
  33. Blumgart, H. L., and A. S. Freedberg,. and C. S. Kurland: Hypothyroidism produced by radioactive iodine (I131) — in treatment of euthyroid patients with angina pectoris and congestive heart failure. Circulation (New York) 1, 1105 (1950).Google Scholar
  34. Blumgart, H. L., and A. S. Freedberg: Hypercholesterinemia, Myxedema and Atherosclerosis. Amer. J. Med. 14, 665(1953).PubMedGoogle Scholar
  35. S. L. Gargill and D. R. Gilligan: Studies on the velocity of blood flow. XIV: The Circulation in myxedema and thyrotoxicosis. J. Clin. Invest. 9, 91 (1930).PubMedGoogle Scholar
  36. Boyd, E. M., and W.F. Cornell: Thyroid Disease and blood lipids. Quart. J. Med. 29, 455 (1936).Google Scholar
  37. Brat, L.: Das Herz bei Myxoedem. Dtsch. Arch. klin. Med. 200, 652 (1953).PubMedGoogle Scholar
  38. Braid, F.: Hypothyroidism in Childhood. Brit. Med. J. 1951, No. 4716, 1169 (1951).Google Scholar
  39. Brewer, D.B.: Myxedema: An autopsied report with histochemical observations on the nature of the mucoid infiltrations. J. of Path. 63, 503 (1951).Google Scholar
  40. Brewster, W. R. Jr., J. P. Isaacs, P. F. Osgood and T. L. King: The Hemodynamic and Metabolic Interrelationsships in the Activity of Epinephrine, Norepinephirne and the Thyroid Gland. Circulation (New York) 13, 1 (1956).Google Scholar
  41. chner, F.: Spezielle Pathologie. München und Berlin: Urban & Schwarzenberg, 1955.Google Scholar
  42. chner, F.:Allgemeine Pathologie, 2. Aufl. München und Berlin: Urban & Schwarzenberg 1956.Google Scholar
  43. Bullrich, R. H., R. Repetto and J. A. Ferrari: Myxedematous effusion. Chronic Cardiac Tamponade. Prensa méd. argent. 31, 2423 (1944).Google Scholar
  44. Burlage, S. R.: The Caracteristic Electocardiogramm of the Cretin Sheep. Proc. Soc. Exper. Biol. a. Med. 19, 425 (1922).Google Scholar
  45. Byrom, F. B.: The Nature of myxedema. Clin. Sci. 1, 273 (1933).Google Scholar
  46. Calvert, R. J., E. Smith and G. Andrews: Coexistant Myxedema Heart Disease and Psychosis. Brit. Med. J. 1954, 891.Google Scholar
  47. COELHO, E.: Les troubles cardiaques dans la maladie de Basedow et le Myxoedème. Ann. de Méd. 30, 3 (1931).Google Scholar
  48. Corcoran, A. C., and I. H. Page: Specific renal function in Hyperthyroidism and Myxedema. J. Clin. Endocrin. 7, 801 (1947).Google Scholar
  49. Cori, G.: Experimentelle Untersuchungen in einem kongenitalen Myxoedem. Z. exper. Med. 25, 150 (1921).Google Scholar
  50. Courcy, J. L. de: Thyroidectomy in the mental disturbed with exophthalmic goiter. Amer. J. Surg. 6, 21 (1929).Google Scholar
  51. Creech, O. Jr., W. H. Hicks, H. B. Snyders and E. E. Erickson: Cholesterol Pericarditis. Successful Treatment by Pericardectomy. Circulation (New York) 12, 193 (1955).Google Scholar
  52. Curschmann, H.: Über Myxoedem der Erwachsenen. Med. klin. 1926, 559.Google Scholar
  53. Curtis, R. H.: Hyponatremia in Primary Myxedema. Ann. Int. Med. 44, 376 (1956).PubMedGoogle Scholar
  54. Dalla, V.: Das -Syndrom der Herzvergrößerung bei Myxödem des Erwachsenen. Wien, med. Wschr. 1943, 301.Google Scholar
  55. Davidson, J. D., W. Meyer and F. E. Kendall: Effect of choline upon experimental arteriosclerosis. Circulation (New York) 3, 332 (1951).Google Scholar
  56. Davis, J. C.: Myxedema Heart with Report of one Case. Ann. Int. Med. 4, 7 (1931).Google Scholar
  57. Davis, C. E., J. MacKinnon and M. M. Patts: Renal Circulation and Cardiac Output on “Low output” Heart Failure and Myxoedema. Brit. Med. J. 1952, 595.Google Scholar
  58. Deane, H. W., and R. O. Greep: A cytochemical study of the adrenal cortex inhypo-and h5rperthyToidism. Endocrinology (Springfield, Ill.) 41, 243 (1947).Google Scholar
  59. Despopoulos, A., and W. H. Perlofp: Pituitary versus primary Myxedema. Amer. J. Med. Sci. 220, 208 (1950).PubMedGoogle Scholar
  60. DeVisscher, M.: Rôle de la sécrétion thyroidienne dans l’action métabolique de l’adrénaline. C. r. Soc. Biol. (Paris) 140, 1205 (1946).Google Scholar
  61. Dietrich, W.: Pluriglanduläre Sklerose bei Myxoedem mit mucoider Degeneration der Skelettmuskulatur. Virchows Arch. 307, 566 (1941).Google Scholar
  62. Doerr, W., u. K. Holldack: Über das Myxoedemherz. Virchows Arch. 315, 651 (1948).Google Scholar
  63. Doxiades, L., u. C. pototzky: Die Benutzung der kardiovasculären Untersuchungsmethoden für die Beurteilung des Myxoedems beim Kinde. Klin. Wschr. 1927, 1326.Google Scholar
  64. Drake, E. H.: A Case of Complete Heart Block with Interesting Reactions to Drugs. Amer. Heart J. 31, 560 (1928).Google Scholar
  65. Dyson, A., and M. W. W. Wood: Triiodothyronine in Myxedema Coma. Lancet 271, No. 6946, 757 (1956).PubMedGoogle Scholar
  66. Eiselberg, a. F.: Über Wachstumsstörungen bei Tieren nach frühzeitiger Schilddrüsen-exstirpation. Arch. klin. Chir. 49, 207 (1895).Google Scholar
  67. Ellis, L. B., J. G. Mebaine, G. Maresk, H. N. Hultgren and R. A. Bloomfield: The effect of myxedema on the cardiovascular system. Amer. Heart. J. 43, 1 (1952).Google Scholar
  68. Engelberg, H., H. B. Jones and B. J. Gofman: Circulation (New York) 4, 477 (1951); zit. nach H. Weicker.Google Scholar
  69. Epstein, A. A., and H. Lande: Studies on blood lipoids. I. The Relation of cholesterol and protein deficiency to basal metabolism. Arch. Int. Med. 30, 563 (1922).Google Scholar
  70. Evans, W.: The Heart in Endocrine Disaese. Proc. Roy. Soc. Med. 42, 331 (1949);PubMedGoogle Scholar
  71. Evans, W.:A Case of Myxedema with Ascites and Atony of the Urinary Bladder. Endocrinology (Springfield, Ill.) 16, 409 (1932Google Scholar
  72. Evans, W.: Myxedema Heart Disease, Treatment and Radiographic Changes. Lancet 1937 II, 1300.Google Scholar
  73. Fahr, G.: Myxedema Heart. J. Amer. Med. Assoc. 84, 345 (1925);Google Scholar
  74. Fahr, G.:Myxedema Heart. Amer. Heart. J. 3, 14 (1927).Google Scholar
  75. Falta, W.: Die Erkrankungen der Blutdrüsen. 1913.Google Scholar
  76. Feasley, w. r.: Pericardial Effusion in myxedema. Amer. Heart J. 19, 749 (1940).Google Scholar
  77. Ferayorini, R. R., and R. G. Sprague: Myxedema with Ascites and Hydrothorax. Proc. Staff Meet. Mayo Clin. 27, 25 (1952).Google Scholar
  78. Fishberg, a. M.: Arteriosclerosis in Thyroid Deficiency. J. Amer. Med. Assoc. 82, 463 (1924).Google Scholar
  79. Foster, M., and Barr, D. P.: Myxedema; record of an autopsied case with special emphasis upon lesions of muscles. J. Clin. Endocrin. 4, 417 (1944).Google Scholar
  80. Fraser, R. W., A. P. Forbes, F. Albright, H. Sulkowitch and E. C. Reifenstein: Colorimetrie assay of 17-ketosteroids in urine. J. Clin. Endocrin. 1, 234 (1941) 4 Fbank Schaub:Google Scholar
  81. Frebdman, H. H., and A. S. Gordon: Effects of thyroidectomy and of thiom-acil on adrenal weight and ascorbic acid. Proc. Soc. Exper. Biol. a. Med. 75, 729 (1950).Google Scholar
  82. Freeman, E. B.: Chronic Pericardial Effusion in Myxedema. Ann. Int. Med. 7, 1070 (1934).Google Scholar
  83. Frisk, A. R., and I. Lindgren: Methylthiouracil in treatment of congestive heart failure and angina pectoris; results of prolonged treatment. Acta med. scand. (Stockh.) 132, 69 (1948).Google Scholar
  84. Froment, R.: Le gros coeur myxoedemateux. Myxoedeme myocardique. Méd. Lyon 1936, 619.Google Scholar
  85. Gascard, E., et L. Pierron: La péricardite myxoedémateuse. Paris méd. 1951, 35.Google Scholar
  86. Gibson, H. G., and A. W. Harris: Clinical Studies of the Blood Volume. V. Hyperthyroidism and myxedema. J. Clin. Invest. 18, 59 (1939).PubMedGoogle Scholar
  87. Gildea, E. F., E. B. Man and J. P. Peters: Serum lipoids and proteins in hypothyroidism. J. Clin. Invest. 18, 739 (1939).PubMedGoogle Scholar
  88. Gofman, J. W., F. T. Lindgren, H. A. Elliott, W. Mantz, J. Hewitt, B. Strisower and V. Herring: The Role of lipids and lipoproteins in atherosclerosis. Science (Lancaster, Pa.) 3, 166 (1950).Google Scholar
  89. H. B. Jones, F. T. Lindgren, T. P. Lyon, H. A. Elliott and B. Strisower: Blood lipids and human atherosclerosis. Circulation (New York) 2, 161 (1950).Google Scholar
  90. H. B. Jones, F. T. Lindgren, T. P. Lyon, H. A. Elliott and B. Strisower., T. P. Lyon, F. Lindgren, B. Strisower, D. Coman and V. Herring: Blood lipids and human atherosclerosis. Circulation (New York) 5, 119 (1952).Google Scholar
  91. Goldberg, S. A.: Changes in organs of thyroidectomized sheep and goats. Quart. J. Exper. Physiol. 17, 15 (1927).Google Scholar
  92. Goldberg, S. A., and I. L. Chaikofp: Myxedema in the radio-thioidectomized dog. Endocrinology (Springfield, lII.) 50, 115 (1952).Google Scholar
  93. Gordon, A. H.: Some clinical aspects of hypoth3rroidism. Canad. Med. Assoc. J. 20, 7 (1929);PubMedGoogle Scholar
  94. Gordon, A. H.:Pericardial effusion in Myxedema. Trans. Assoc. Amer. Physicians 50, 272 (1935).Google Scholar
  95. Gräsbeck, R., and B. A. Lamberg: The Electrophoretic Lipoprotein Pattern in Disorders of Thyroid Function. Acta endocrinol. (Copenh.) 19, 82 (1955).Google Scholar
  96. Hallock, p.: The Heart in Myxedema with a Report of two Cases. Amer. Heart J. 9, 196 (1933).Google Scholar
  97. Hamburger, W. W., M. W. Lev, W. S. Priest and H. C. Hovard: The Heart in Thyroid Disease. Arch. Int. Med. 43, 1 (1929).Google Scholar
  98. Harrell, G. T., and C. Johnston: Pericardial Effusion in Myxedema. Amer. Heart J. 25, 505 (1943).Google Scholar
  99. Heckscher, H.: Über die Fett-Cholesterinmenge des Blutes bei Eó-etinen. Z. Biochem. 158, 422 (1928).Google Scholar
  100. Higgins, W. H.: The Heart in Myxedema. Amer. J. Med. Sci. 191, 80 (1936).Google Scholar
  101. Hoelzer, H.: Über die Arteriosklerose im Kindesalter bei angeborenem vollkommenem Schilddrüsenmangel. Zugleich ein Beitrag zur Funktion der Schilddrüse und zur Arteriosklerosis- frage. Beitr. path. Anat. 104, 289 (1940).Google Scholar
  102. Hoffman, F., E. J. Hoffman and J. Talesnik: The influence of thyroxine and cortical extract on the oxygen consumption of adrenalectomized rats. J. of Physiol. 107, 251 (1948).Google Scholar
  103. Hoffman, F., E. J. Hoffman and J. Talesnik., O. Cori and A. T. de Cori: Acta physiol. lat.-amer. 1, 84 (1951); zit nach Abelin u. Goldstein.Google Scholar
  104. Holldack, K.: Beobachtungen am Myxoedemherzen. Dtsch. med. Wschr. 1949, 16.Google Scholar
  105. Holzman, J. E.: Myxedema Heart. Amer. Heart J. 4, 351 (1929).Google Scholar
  106. Holzmann, M.: Klinische Elektrokardiographie. Thieme-Verlag 1956.Google Scholar
  107. Holzmann, M.:Erkrankungen des Herzens und der Gefäße, in H. R. Schinz, W. E. Baensch, E. Friedl, E. Uehlinger: Lehrbuch der Röntgendiagnostik, Bd. III. Stuttgart: Georg Thieme 1952.Google Scholar
  108. Horstman, P.: The Effect of Adrenaline on the Oxygen Consumption in Diabetes mellitus and in Hyperthyroidism. Acta endocrinol. (Copenh.) 16, 233 (1954).Google Scholar
  109. Houssay, H. E. J.: Tiroides e hipertrofia cardiaca. Rev. argent. Cardiol. 22, 34 (1955).Google Scholar
  110. Hurxthal, L. M.: Blood cholesterol in thyroid disease. III. Myxedema and hyperchol- esterinemie. Arch. Int. Med. 53, 762 (1934).Google Scholar
  111. Jahnke, K.: Klinische Ultrazentrifugen-Untersuchungen. III. Mitteilungen. Die Lipoid- proteine im Serum, ihre Differenzierung und klinische Bedeutung. Z. exper. Med. 125, 59 (1955).Google Scholar
  112. Jeffers, W. A., E. Rose and Littman, D. S.: Infrequency of Myocardial Infarction in Patients with Thyrotoxicosis. Circulation (New York) 14, 957 (1956).Google Scholar
  113. Ingle, D. J., and G. M. Higgins: The Effects of Thyroxin on the extent of Regeneration in the enucleated Adrenal Gland of the Rat. Endocrinology (Springfield, Ill.) 41, 243 (1947).Google Scholar
  114. Jones, R. J., L. Cohen and H. Corbus: The Serum Lipid Pattern in Hyperthyroidism, Hypothyroidism and Coronary Atherosclerosis. Amer. J. Med. 14, 71 (1955).Google Scholar
  115. Jores, A.: Handbuch der Inneren Medizin, Bd. 7, I.Teil. Berlin-Göttingen-Heidelberg: Springer 1955.Google Scholar
  116. Kaunitz, H.: Hydroperikard bei inrektorischer Störung. Z. klin. Med. 130, 601 (1936).Google Scholar
  117. Kern, R. A., L. A. Soloff, W. J. Snape and C. T. Bello: Pericardial Effison: a constant, early and major factor in the cardiac syndrome of hypothyroidism (myxedema heart). Amer. J. Med. Sci. 217, 609 (1949).PubMedGoogle Scholar
  118. Kimble, S. T., and E. J. Stieglitz: Hypothyroidism: a Geriatric Problem. Geriatrics 7, 20 (1952).PubMedGoogle Scholar
  119. Klein, E.: Die Elektrophorese der Serumlipoproteine. Dtsch. med. Wschr. 1956, 1808.Google Scholar
  120. Kleinsorg, H., H. L. Krüskemper, C. Lopez-Calle ja: Serumeiweißveränderungen bei experimenteller Hypothyrose nach Zufuhr von Jod131. Acta endocrinol. (Copenh.) 19, 157 (1955).Google Scholar
  121. Knight, R. A.: The Use of Spinal Anaesthesia to Control Sympathetic Overactivity in Hyperthyroidism. Anesthesiology 6, 225 (1945).Google Scholar
  122. Korrodi, H.: Der Radiojodtest in der Diagnose latenter Hypothyreosen. Helvet. med. Acta 21, 4/5, 419 (1954).PubMedGoogle Scholar
  123. Korth, C., J. Schmidt: Neue Beobachtungen zum,,Myxoedemherzen”. Dtsch. Arch, klin. Med. 202, 437 (1955).Google Scholar
  124. Kountz, W. B.: Vascular degeneration in hypothyroidism. Arch. Path. 50, 765 (1952).Google Scholar
  125. Kountz, W. B.:Thyroid Function and its possible Role in Vascular Degeneration. Springfield, Ill.: Charles C. Thomas 1954.Google Scholar
  126. Kountz, W. B., and L. H. Hepelmann: Chromatic degeneration and rupture of aorta following thyreoidectomy in cases of hjrpertension. Amer. Heart J. 20, 599 (1940).Google Scholar
  127. Krane, S. M., G. L. Brownell, J. B. Stanbury and H. Corrigan: The Effect of Thyroid Disease on Calcium Metabolism in Man. J. Clin. Invest. 35, 874 (1956).PubMedGoogle Scholar
  128. Kroetz, C., u. W. Fischer: Zur Blutchemie der akuten, fortschreitenden Arteriosklerose, elektrophoretische Lipoproteinbestimmungen bei Atheromatose und Atherosklerose. Dtsch. med. Wschr. 1954, 633.Google Scholar
  129. Kroneberg, G., u. F. Huter: Der Einfluß von Thyroxin auf die Toxicität des Adrenalins und des Arterenols. Klin. Wschr. 1951, 649.Google Scholar
  130. Krüskemper, H. L.: Untersuchungen über die Beziehungen zwischen Schilddrüsen- und Nebennierenrinden-Hormon Wirkungen im Gewebestoffwechsel. Acta endocrin. (Copenh.) 19, 21 (1955).Google Scholar
  131. Kurland, G. S., R. E. Schneckloth, A. S. Freedberg: The Heart in I131 Induced Myxedema. New England J. Med. 249, 215 (1953).Google Scholar
  132. Labhart, A.: Klinik der inneren Sekretion. Berlin-Göttingen-Heidelberg: Springer 1957.Google Scholar
  133. LaDue, J. S.: Myxedema Heart: A pathological and therapeutic Study. Ann. Int. Med. 18, 332 (1943).Google Scholar
  134. Lamberg, B. a., and R. Gräsbeck: The Serum Protein Pattern in Disorders of Thyroid Function. Acta endocrinol. (Copenh.) 19, 91 (1955).Google Scholar
  135. Lange, K.: Capillary Permeability in Myxedema. Amer. J. Med. Sei. 208, 5 (1944).Google Scholar
  136. Laubry, C., Mussio-Fournier et J. Walser: Syndrome angineux et insuffisance thyroidienne. BuU. Soc. Hop. Paris 48, 1592 (1924).Google Scholar
  137. Lemaire, a., et J. Cottet: Le syndrome biochimique de l’athérosclérose animale. Presse méd. 1955, 1339.Google Scholar
  138. Lemaire, a., et J. Cottet., et S. Led ermann: Le syndrome biochimique de l’athérosclérose humaine. Presse méd. 1956, 1129.Google Scholar
  139. Enselme, J. Cottet, P. Cassassus et Tigaud: Les lipoprotéines du sérum, leur étude par électrophosphorèse de zone sur papier. Ann. de Méd. 57, 5 (1956).Google Scholar
  140. Le Marquand, H. S., W. Hausmann and E. H. Hemsted: Death in Myxedema. Brit. Med. J. 1953, 704.Google Scholar
  141. Lerman, J:. J Amer. Med. Assoc. 117, 349 (1941); zit. NachGoogle Scholar
  142. M. Richard, Die Hypothyreose. Schweiz, med. Wschr. 1952, 913.Google Scholar
  143. Lerman, J: Myxedema Heart. J. Clin. Endocrin. 14, 477 (1954).Google Scholar
  144. R. J. Clark, and J. H. Means: The Heart in Myxedema: Electrocardiogramme and Röntgen ray measurements before and after therapy. Ann. Int. Med. 6, 1291 (1933).Google Scholar
  145. Lesser, H., and E. M. Anderson: Three Cases of Adult Myxedema in Women. Endocrinology (Springfield, Ill.) 15, 5 (1931).Google Scholar
  146. Levin, M. E., and W. H. Daughady: Fatal Coma Due to Myxedema. Amer. J. Med. 18, 1017 (1955).PubMedGoogle Scholar
  147. Lewis, L. A., A. A. Green and I. H. Page: Ultracentrifuge Lipoprotein Pattern of Serum of normal, hjrpertensive and hjrpothyroid animal. Amer. J. Physiol. 171, 391 (1952).PubMedGoogle Scholar
  148. Lijung, O.: Mild Hypothyroidism causing Electrocardiographic Changes Suggesting Coronary Insufficiency. Acta med. scand. (Stockh.) 137, 120 (1950).Google Scholar
  149. Littmann, D. S. e. c.: The Infrequency of Myocardial Infarction in Patients with Thyrotoxicosis. Amer. J. Med. Sci. 233, 10, (1957).Google Scholar
  150. Lueg, W.: Über das Elektrokardiogramm des Myxoedems. Z. klin. Med. 104, 337 (1926).Google Scholar
  151. Luetscher, J. A. Jr., and R. h. Curtis: Aldosterone; Observations on the Regulation of Sodium and Potassium Balance. Ann. Int. Med. 43, 658 (1955).PubMedGoogle Scholar
  152. Luten, D.: Myxedema with Partial Heart Block and Severe Anemia Both of which disappeared under thyroid therapy. J. Missouri Med. Assoc. 26, 73 (1920).Google Scholar
  153. Lutolf, W.: Untersuchungen über die Sensibilisierung von Adrenalin durch Thyroxin am überlebenden Säugetierherzen. Z. Biol. 90, 334 (1930).Google Scholar
  154. Macy, J. W., T. S. Claiborne and L. M. Hurxthal: The Circulation Rate in Relation to Metabolism in Thyroid and Pituitary States (Decholin Methode). J. Clin. Invest. 15, 37 (1936).PubMedGoogle Scholar
  155. Madenberg, F.: Occurrence of Ascites in Myxedema. Arch. Int. Med. 93, 787 (1954).Google Scholar
  156. Mahaux, J., et E. Koiw: Protéinogramme et lipidogramme sur papier filtre dans le myx- oedème. Action de la thyroxine’. Ann. d’Endocrin. 13, 691 (1952).Google Scholar
  157. Malden, M.: Hypothermic Coma in Myxedema. Brit. Med. J. No. 4942, 764, 1955.Google Scholar
  158. Malbcros, H., and B. Swahn: Lipid metabolism in myxedema. Acta med. scand. (Stockli.) 145, 361 (1953).Google Scholar
  159. Mancini, R. E., J. C. Garb eri and F. A. de la Balze: Mucoproteines of the connective tissue of the skin in generalized myxedema. J. Nat. Cancer Inst. 13, 247 (1952).PubMedGoogle Scholar
  160. March, H. E.: Myxedematous Ascites Removed by Thyroid Extract. Amer. J. Med. Sci. 172, 585 (1926).Google Scholar
  161. Marchand, F.: Über einen Fall von sporadischem Kretinismus und Myxoedem mit fast totaler Aplasie der Schilddrüse. Münch, med. Wschr. 1440, 1906.Google Scholar
  162. Margitay-Becht, A.: Der Natriumgehalt des Blutserums bei Myxoedem. Klin. Wschr. 1937, 1353.Google Scholar
  163. Marks, P. A., and B. S. Roff: Pericardial effusion associated with myxedema. Ann. Int. Med. 39, 230 (1953).PubMedGoogle Scholar
  164. Marshall, R. J., McCaughey W. T. E.: Hjrpothermic Myxedema Coma with Muscle Damage and Acute Renal Tubular Necrosis. Lancet 1956, 6946, 754.Google Scholar
  165. Martius, C.: Die Wirkungsweise desSchüddrüsenhormones, in:Hormone und ihre Wirkungsweise. Berlin-Göttingen-Heidelberg: Springer 1955.Google Scholar
  166. Marzullo, E. R., and S. Franco: Myxedema with multiple serous effusions and cardiac involvement (myxedema heart) Case Report. Amer. Heart J. 17, 368 (1939).Google Scholar
  167. McCubbin, j. W., and I. H. Page: Effect of athyroid state on vascular reactivity and arterial pressure in neurogenic and renal hypertensive dogs. Circulation (New York) 5, 397 (1952).Google Scholar
  168. McGavack, T. H.: The Thyroid. St. Louis: Mosby 1951.Google Scholar
  169. McGavack, T. H., K. Lange and D. Schwimmer: Management of the Myxedematous Patients with Symptoms of Cardiovascular Disease. Amer. Heart. J. 29, 421 (1945).Google Scholar
  170. McGavack, T. H., Means, J. H.: The Thyroid and its Disease. Philadelphia: J. B. Lippincot Co. 1948.Google Scholar
  171. McGavack, T. H:Hypothyroid Heart Disease. New England J. Med. 208, 541 (1933).Google Scholar
  172. P. D. White and C. Krantz: Observations on the Heart in Mxyedema with Special Reference to Dilatation and Angina pectoris. Boston Med. J. 195, 351 (1926).Google Scholar
  173. Meissner, R.: Zur Klinik des Myxoedemherzens. Münch, med. Wschr. 1920, 1316.Google Scholar
  174. Merkel, H.: Beitr. path. Anat. 104, 332 (1940);Google Scholar
  175. Merkel, H.: Arch. Kreislaufforsch. 9,283 (1941); zit. nach F. Büchner.Google Scholar
  176. Misske, B.: Das Elektrokardiogramm des Mxyoedemherzens. Z. Kreislaufforsch. 28, 601 (1936).Google Scholar
  177. Neter, E.: Untersuchungen über die reflektorische Selbststeuerung des Kreislaufes bei experimenteller Thyreotoxikose. Arch, exper. Path. u. Pharmakol. 174, 416 (1936).Google Scholar
  178. Nobel, E., A. Rosenblüth u. B. Samet: Das Elektrokardiogramm des kindlichen Myxoedems. Z. exper. Med. 43, 332 (1924).Google Scholar
  179. ss, F. J.: Die sog. Cholesterin-Perikarditis. Ärztl. Forsch. 9,1, 526 (1955).Google Scholar
  180. Ohler, W. R., and J. Abramson: The Heart in Myxedema. Arch. Int. Med. 53, 165 (1934).Google Scholar
  181. Oliver, M. F., and G. S. Boyd: The Influence of Triiodothyroacetic Acid on the Circulating Lipids and Lipoproteins in euthyroid men with coronary disease. Lancet 1957, No. 6960, 124.Google Scholar
  182. Ord, W. M.: Cases of Myxedema. Trans. Clin. Soc. London 13, 15 (1880).Google Scholar
  183. Page, I. H.: Atherosclerosis. An Introduction. Circulation (New York) 10, 1 (1954).Google Scholar
  184. Page, I. H., and H. B. Brown: Induced Hypercholesterolemia and Atherogenesis. Circulation (New York) 6, 681 (1952).Google Scholar
  185. Page, I. H.:and J. W. McCubbin: Influence of Thyroid Function on Vascular Reactivity in Dogs. Circulation (New York) 3, 397 (1952).Google Scholar
  186. Parsons, W. H., and W. K. Purks: Total Thyroidectomy for heart disease. Ann. Surg. 105, 722 (1937).PubMedGoogle Scholar
  187. Paterson, J. C., B. B. Cornisk and E. C. Armstrong: The Serum Lipids in Human Atherosclerosis. Circulation (New York) 13, 224 (1956).Google Scholar
  188. Pathy, M. S.: a Case of Myxedema with Serous Effusions. Brit. Med. J. 1955, No. 4942, 772.Google Scholar
  189. Pekkarinen, a., M. Koivusolo and K. Pyorola: Investigation of the Effect of Thyroid Preparations and of Methylthiouracil on the Adrenal Glands and Chemistry as well as on some others Organs. Acta endocrinol. (Copenh.) 6, 233 (1951).Google Scholar
  190. Peltola, p.: Adrenal sensitization induced by Experimental Herthyroidism. Acta med. scand. (Stockh.) 140, Suppl. 262 (1951).Google Scholar
  191. Pick, E., u. P. Pineles: Untersuchungen über physiologisch wirksame Substanz der Schilddrüse. Z. exper. Path. u. Ther. 7, 518 (1909).Google Scholar
  192. Pick, E., u. P. Pineles:Über die Beziehungen der Schilddrüse zum Gefäßsystem. 25. Kongreß inn. Med. 25, 306 (1908).Google Scholar
  193. Pickering, D. E., D. A. Fisher and K. G. Scott: Growth and Metabo Hsm in normal and Thjnroid-ablated Infant Rhesus Monkey (Macaca mulatta). Amer. J. Dis. Childr. 86, 157 (1984)Google Scholar
  194. Pratt, G. P., and H. B. Morton: Management of the Circulation in Myxedema. Amer. J. Med. Sci. 173, 274 (1927).Google Scholar
  195. Preston, M. I.: Effects of Thyroxin on the mouse Adrenal. Endocrinology (Springfield, lII.) 12, 323 (1928)..Google Scholar
  196. Raab, W.: Epinephrine Tolerance of the Heart altered by Thyroxine and Thiouracil. J. Pharmacol, a. Exper. Ter. 82, 330 (1944).Google Scholar
  197. Raab, W.:Diminuition of Epinephrine Sensitivity of normal Human Heart through thiouraco. J. Labor, a. Clin. Med. 30, 774 (1945).Google Scholar
  198. Raab, W.:Hormonal and Neurogenic Cardiovascular Disorders. Baltimore: Williams and Wilkins 1953.Google Scholar
  199. Ramey, E. R., H. Bernstein and M. S. Goldstein: Effect of Sympathetic Blocking Agents on the Increased Oxygen Consumption following Administration of Thyroxine. Federat. Proc. 14, 118 (1955).Google Scholar
  200. Ravéra, J. J.: Myxoedème avec insuffisance cardiaque, angine de poitrine et épanchement pleural. Evolution favorable par le traitement thyroïdien. BuU. Acad. Nat. Méd. 138, 537 (1957)Google Scholar
  201. Rea, C. E.: A new plan in the operative treatment of patients with severe Hyperthyroidism. Surgery 16, 731 (1944).Google Scholar
  202. Read, J. M.: Treatment of the Cardiac Disturbances due to Thyroid Disease. J. Amer. Med. Assoc. 89, 493 (1927).Google Scholar
  203. Reid, W. D., and F. V. Kenway: Electrocardiographic Signs Associates with Low Basal Metabollsm. Endocrinology (Springfield, Ill) 13, 191 (1929).Google Scholar
  204. Richard, M.: Die Hjothyreose. Schweiz, med. Wschr. 1952, 913.Google Scholar
  205. Ring, G. C.: The importance of the Thyroid in Maintaining an Adequate Production of Heart During exposure to Cold. Amer. J. Physiol. 137, 582 (1942).Google Scholar
  206. Robertson, J. D.: Calcium and Phosphorus Studies in Myxedema. Lancet 1941 II, 216.Google Scholar
  207. Rosenblijm, H., R. G. Hahn and S.A. Levine: Epinephrine; its Effect on the Cardiac Mechanism in Experimental Hjrperthyroidism and Hypothyroidism. Arch. Int. Med. 51, 279 (1933).Google Scholar
  208. Rosenman, R. H., M. Friedman and S. O. Byers: Observations concerning the Metabolism of Cholesterol in the Hjrpo- and Hyperthyroid Rat. Circulation (New York) 5, 589 (1952).Google Scholar
  209. ssle, R.: Über Myxoedem bei totaler Thyreoaplasie. Korresp. bl. ärztl.Ver. Tübingen H. 1/2 (1920).Google Scholar
  210. Sainton, P., E. Doumer et P. ran: Syndrome cardiorénal et hypothyroidie. Ann. de Méd. 24, 513 (1928).Google Scholar
  211. Sato, H.: Studies on the Cardiac Rythm of the dog in Experimental Hyper- and Hjrpo- thyroidism. Tokoku J. Exper. Med. 53, 317 (1951); ref. in Circulation (New York) 5, 140 (1952).Google Scholar
  212. Sawyer, M. E. M., and M.G. Brown: Effect of Thyroidectomy and Thjrroxine on the Response of the Denervated Heart to injected and secreted Adrenin. J. Amer. Physiol. 110, 620 (1935).Google Scholar
  213. Schantz, E. T., and A. W. Ditbbs: Complete auriculoventricular Block in Myxedema with Reversion to normal Sinus Rhythm on Thyroid Therapy. Amer. Heart J. 41, 613 (1951).PubMedGoogle Scholar
  214. Schaijb, F.: Über die Herzveränderungen bei Myxoedem und einfacher Hypothnreose, Cardiologia (Basel) 30, 185 (1957).Google Scholar
  215. Scheinberg, P., E. A. Stead Jr., E. S. Brannon and J. V. Warren: Correlative Observations on cerebral Metabolism and cardiac output in Myxedema. J. Clin. Invest. 29, 1139 (1950).PubMedGoogle Scholar
  216. Schermann, S. J.: Die Reaktion des isoUerten Herzens eines thyreoidectomierten Tieres auf Adrenalin. Arch, exper. Path. u. Pharmakol. 126, 10 (1927). 8 Fraiste: Schaub:Google Scholar
  217. Schettler, G.: Schilddrüse und Cholesterin. Beitrag zur thyreostatischen Therapie mit Aminothiazol und Methylthiouracil. Z. exper. Med. 115, 251 (1950);Google Scholar
  218. Schettler, G.:Arteriosklerose und Cholesterinstoffwechsel. Dtsch. med. Wschr. 1953, 989; Lipidosen, Handbuch der Inneren Medizin, Bd. 7, 2. Teil. Berlin-Göttingen-Heidelberg: Springer 1955; Die Pathogenese der Arteriosklerose als Stoffwechselproblem. Erg. inn. Med. N. F. 6, 278 (1955).Google Scholar
  219. H. Jobst: Die Bedeutung alimentärer Fettbelastung für die Diagnose der Arteriosklerose. Dtsch. med. Wschr. 1955, 1077.Google Scholar
  220. Schittenhelm, A., u. B. Eisler: Über die Wirksamkeit des Thyroxins bei endokrin bedingten Störungen. Khn. Wschr. 1927, 1935.Google Scholar
  221. Schleshstger, B., and B. Landtman: Electrocardiographic Studies in Cretins. Brit. Heart J. 10, 237 (1948).Google Scholar
  222. Schmidt, S.: Pericardial effusion in Myxedema. Brit. J. Radiol. 25, 389 (1952).PubMedGoogle Scholar
  223. schneckloth, R. E., G. E. kurland and A. s. Freedberg: Effect of Variations in Thiroid Function on the Pressor response to Norepinephrine in Man. Metabolism 2, 546 (1953).PubMedGoogle Scholar
  224. Schnitzer, R., and D. Gutman: Myxedema with Pericardial Effusion. Brit. Heart J. 8, 25 (1946).Google Scholar
  225. Schultz, A.: Über einen Fall von Athyreosis congenita (Myxoedem) mit besonderer Berücksichtigung der dabei beobachteten Muskel Veränderungen. Virchows Arch. 232, 302 (1941).Google Scholar
  226. Schrenwood, G.: Treatment of Angina pectoris by Reduction of Metabolism. Brit. J. Med. 1948,1251.Google Scholar
  227. Seely, H., and E. C. Cutler: Effect of total Thjo-eoidectomy on Response to Injection of Adrenalm. Proc. Soc. Exper. Biol. a. Med. 34, 23 (1936).Google Scholar
  228. Selenkow, H. A., u. S. P. Asper Jr.: Wirksamkeit von peroralem Trijodothjrronin und Thyroxin in der Behandlung des Myxoedems. J. Clin. Endocrin. 86, 53 (1956).Google Scholar
  229. Shapiro, S.: Relation of certain Glands of Internal Secretion to the Development of Ather- sclerosis. Endocrinology 11, 279 (1927)Google Scholar
  230. Shapiro, S.:Influence of Thyroidectomy, Splenectomy, Gonadectomy and Suprarenalectomy upon Development of experimental Atherosclerosis in Rabbits. J. of Exper. Med. 45, 595 (1927).Google Scholar
  231. Smith, D. J.: Immediate Sensitization of isolated Swine arteries and their Vasa Vasorum to Epinephrine, Acetylcholine and Histamine by Thiroxine. Amer. J. Physiol. 177, 7 (1954).PubMedGoogle Scholar
  232. Smyth, C. J.: Angina pectoris and myocardial infarction as complications of myxedema with special reference to treatment with thyroid preparations. Amer. Heart J. 15, 652 (1938).Google Scholar
  233. Soffer, A., P. N. G. Yu and D.A. Epstein: Serum Lipid Studies in euthyroid Subjects foUowing the Administration of Thyroid. Amer. J. Med. Sei. 222, 427 (1951).Google Scholar
  234. Sommerville, W., and S. A. Levine: Angina pectoris and Thyreotoxicosis. Brit. Heart J. 1, 245 (1950).Google Scholar
  235. Starr, P., and R. Liebhold-Schneck: The Effect of Levo-Thyroxine, Dextrothyroxine and Levo-Jodo-Thyronine on the Electrocardiogramm in Myxedema. Preliminary Rep. Ann. Int. Med. 42, 595 (1955).Google Scholar
  236. Statland, H., and J. Lerman: Function of the Adrenal Cortex in Myxedema with some Observations on pituitary Function. J. Clin. Endocrin. 10, 1401 (1950).Google Scholar
  237. Steiner, A., and F. E. Kendall: Atherosclerosis and arteriosclerosis in Dogs following Ingestion of Cholesterol and Thiouracil. Arch, of Path. 42, 433 (1946).Google Scholar
  238. Steiner, A., and F. E. Kendall and M. Be vans: Production of Arteriosclerosis in Dogs by Cholesterol and Thiouracil feeding. Amer. Heart J. 38, 34 (1949).PubMedGoogle Scholar
  239. Stewart, H. J., J. E. Dietrick and N. F. Crane: Studies of the Circulation on Patients suffering from spontaneous Myxedema. J. Clin. Invest. 17, 237 (1938).PubMedGoogle Scholar
  240. Strisower, B., J. W. Gofman, E. G. Galioni, J. H. Rubinger, J. Pouteau and P. Cuzvich: Long-Term-Effect of Dried Thyroid on Serum-Lipoprotein and Serum-Cholesterol Levels. Lancet 1957, No. 6960, 120.Google Scholar
  241. Sturgis, C. C.: Angina pectoris as a Complication in Myxedema and Exophthalmus Goiter. Boston Med. J. 195, 351 (1926).Google Scholar
  242. Sturgis, C. C and W. B. Whiting: The Treatment and Prognosis in Myxedema J. Amer. Med. Assoc. 85, 2013 (1925).Google Scholar
  243. Swan, J. M.: Case of Auricular Fibrillation Occuring during the Administration of Thyroid Substance. Ann. Clin. Med. 3, 311 (1924).Google Scholar
  244. Talbot, N. B., and A. M. Butler: J. Clin. Endocrin. 26, 129, 1940; zit. nachGoogle Scholar
  245. M. Richard: Die Hypothjrreose. Schweiz, med. Wschr. 1952, 913.Google Scholar
  246. Tatum, a. L.: Morphologic Studies in Exprimental Cretinism. J. of Exper. Med. 17,636 (1913).Google Scholar
  247. Thacher, C.: The Electrocardiogramm in Cretinism and Mongolian Idiocy. Amer. J. Dis. Chüdr. 28, 25 (1924).Google Scholar
  248. Thacher, C and P. D. White: The Electrocardiogramm in Myxedema. Amer. J. Med. Sei. 171, 61 (1926).Google Scholar
  249. Thompson, K. W., and C.N. H. Long: Endocrinology (Springfield, Ill.) 28, 715 (1941); zit. nach Weicker Das Herz bei Myxödem und Hypothyreose 9Google Scholar
  250. Thompson, W.: The Blood Volume in Myxedema with a Comparison of the Plasma Volume Changes in Myxedema and Cardiac Edema. J. Clin. Invest. 2, 477 (1926).PubMedGoogle Scholar
  251. Thompson, W. O., L. N. P. Diceb, A. E. Mobbis and B. H. Hblvitch: The High Incidence of Hypertension in Toxic goiter and in Myxedema. Endocrinology (Springfield, Ill.) 15, 265 (1931).Google Scholar
  252. Thurnhbrb, A.,u.W. Nibderbergbr: Neuere Auffassungen über Aetiologie und Therapie der Atherosklerose unter besonderer Berücksichtigung von Heparin. Schweiz, med. Wschr. 285;Google Scholar
  253. Thurnhbrb, A:Lipoproteinstudien zur Ätiologie und Therapie der Arteriosklerose. Bull. Schweiz. Akad. med. Wiss. 12, 1 (1956).Google Scholar
  254. Tung, C. L.: The Status of the Heart in Myxedema. Amer. Heart J. 6, 734 (1931).Google Scholar
  255. Tucker, H. St. G., J. L. Chitwood and C. P. Parker: Pituitary Myxedema, Report of 3 Cases. Ann. Int. Med. 32, 52 (1950).PubMedGoogle Scholar
  256. Urschel, D. L., and G. E. Gates: Mean Spatial Vectorcardiography. The Vector Changes in. Hypothyroidism. Amer. Heart J. 46, 611 (1953).Google Scholar
  257. Walker, J. E.: Hypothyroidism associated with Cardiac Enlargement (Myxedema Heart) and Auricular FibriUation. J. Amer. Med. Assoc. 100, 1025 (1933).Google Scholar
  258. Wartman, W. B., and W. T. Hill: Degenerative Diseases, in Gould, S.E.: Pathology of the Heart. Springfield, Ill.: Charles C. Thomas 1953.Google Scholar
  259. Watson, E. M., and R. H. Pearce: The Mucopolysaccharide content of the Skin in localized (pretibial) Myxedema. Amer. J. Clin. Path. 17, 507 (1947).Google Scholar
  260. Webster, B., and C. Cooke: Morphologic Changes of the Heart in Experimental Myxedema. Arch. Int. Med. 58, 269 (1936).Google Scholar
  261. Wegelin, C.: Die Schüddrüse. In Handbuch der speziellen pathologischen Anatomie und Histologie von Henkb-Lubarsch, Bd. 8. Berlin 1926.Google Scholar
  262. Weicker, H.: Die Lipoideiweißkomplexe bei Myxödem und Hyperthyreose. Acta Endocrin. (Copenh.) 22, 73 (1956).Google Scholar
  263. Weicker, H.: Die Lipoproteine bei Schüddrüsenerkrankungen. Ärztl. Wschr. 1956, 100.Google Scholar
  264. Werner, S. C.: The Thyroid. A Fundamental and Clinical Test. New York: P. B. Hoeber Inc.Google Scholar
  265. Weyker, R. T.: Myxedema Heart. J. Amer. Med. Assoc. 153, 639 (1953).Google Scholar
  266. White, P. D., and J. C. Aub: The Electrocardiogramm in Thiroid Disease. Arch. Int. Med. 22, 766 (1918).Google Scholar
  267. Willius, F. A.: Thyroid Preparations in the Treatment of the Stokes-Adams-Syndrome. Canad. Med. Assoc. J. 14, 1072 (1924).PubMedGoogle Scholar
  268. Willius, F. A.: Cardiac Clinics; Clinic in Advanced coronary Sclerosis with congestive Heart Failure in young Adult, juvenile Myxedema. Proc. Staff Meet. Mayo Clin. 11, 557 (1936).Google Scholar
  269. Willius, F. A.,and S. F. Haines: Status of the Heart in Myxedema. Amer. Heart J. 1, 67 (1925).Google Scholar

Copyright information

© Springer-Verlag OHG. Berlin · Göttingen · Heidelberg 1958

Authors and Affiliations

  • Frank Schaub
    • 1
  1. 1.Medizinische Universitäts-Poliklinik, KantonsspitalZürichSchweiz

Personalised recommendations